IP Verse

Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of Antibodies

Patent No. EP2073842 (titled "Use Of Human Cells Of Myeloid Leukaemia Origin For Expression Of Antibodies") was filed by Glycotope on Sep 10, 2007. The application was issued on Oct 18, 2023.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIESSep 29, 2015REGIMBEAU

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2073842

GLYCOTOPE
Application Number
EP07818090A
Filing Date
Sep 10, 2007
Status
Patent Maintained As Amended
Sep 15, 2023
Publication Date
Oct 18, 2023
External Links
Slate, Register , Google Patents